Francis Chou
Chou Associates Management
Chou Associates Management Portfolio 13F
Francis Chou Holdings Activity
- Portfolio value:
- $301.42M≈ (-$11M≈)
- Previous value:
- $312.74M≈
- # of changes:
- 9
- New positions:
- 2
- Reported for:
- 31 Mar 2017 (Q1)
- Latest filing date:
- 12 May 2017
Chou Associates Management has disclosed a total of 9 changes to the portfolio in the (2017 Q1) SEC report(s): increased the number of shares of 2, bought 2 totally new, decreased the number of shares of 3 and completely sold out 2 position(s).
What stocks did Francis Chou buy in 2017 Q1?
What did Francis Chou invest in during 2017 Q1?
9 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ENDO HEALTH SOLUTIONS INC COM
|
new
|
$11.16
|
|
3.52%
|
2017 Q1
|
≈ 0.25 years
|
||||
|
|
Teva Pharma Industries Ltd ADR
|
new
|
$32.09
|
-3.53%($30.96)
|
2.29%
|
2017 Q1
|
≈ 0.25 years
|
||||
|
|
SandRidge Energy Inc
|
+224.67%
|
$18.49
|
-24.64%($13.94)
|
0.96%
|
2016 Q4
|
≈ 0.50 years
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
+20.04%
|
$11.03
|
|
8.61%
|
2016 Q1
|
≈ 1.25 years
|
||||
|
|
Nokia Corp ADR
|
-26.67%
|
$5.42
|
+69.83%($9.20)
|
4.94%
|
2013 Q2 or earlier
|
≈ 4.00+ years
|
||||
|
|
BANK OF AMERICA CORP-CW19
|
-35.85%
|
$11.30
|
|
2.01%
|
2013 Q2 or earlier
|
≈ 4.00+ years
|
||||
|
|
JPMORGAN CHASE & CO-CW18
|
-44.39%
|
$46.31
|
|
9.62%
|
2014 Q4
|
≈ 2.50 years
|
||||
|
|
GlaxoSmithKline PLC ADR
|
-100%
|
$24.10
|
+112.68%($51.25)
|
0.00%
|
2013 Q4
|
≈ 3.25 years
|
||||
|
|
AstraZeneca PLC
|
-100%
|
$54.69
|
|
0.00%
|
2013 Q4
|
≈ 3.25 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.